RAN-PREGABALIN
« Back to list view

Product Information

  • DIN:
    02392801
  • Active Ingredients :
    pregabalin
  • Innovator Name:
    Lyrica®
  • Category:
    Analgesic Agent
  • Dosage form:
    Capsule
  • Strength:
    25 mg
  • Package size:
    100 Bottle 500 Bottle
  • UPC Code:
    876515004716 876515004723
  • Non-medicinal ingredients :
    Mannitol and talc. The capsule shells contain gelatin and titanium dioxide. In addition, the capsule shells contain iron oxide red and sodium lauryl sulfate. The markings on the capsules are in black ink, which contains black iron oxide, potassium hydroxide, propylene glycol, and shellac
RAN-PREGABALIN

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02392828
  • Active Ingredients :
    pregabalin
  • Innovator Name:
    Lyrica®
  • Category:
    Analgesic Agent
  • Dosage form:
    Capsule
  • Strength:
    50 mg
  • Package size:
    100 Bottle 500 Bottle
  • UPC Code:
    876515004730 876515004747
  • Non-medicinal ingredients :
    Mannitol and talc. The capsule shells contain gelatin and titanium dioxide. In addition, the capsule shells contain iron oxide red and sodium lauryl sulfate. The markings on the capsules are in black ink, which contains black iron oxide, potassium hydroxide, propylene glycol, and shellac
RAN-PREGABALIN

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02392836
  • Active Ingredients :
    pregabalin
  • Innovator Name:
    Lyrica®
  • Category:
    Analgesic Agent
  • Dosage form:
    Capsule
  • Strength:
    75 mg
  • Package size:
    100 Bottle 500 Bottle
  • UPC Code:
    876515004754 876515004761
  • Non-medicinal ingredients :
    Mannitol and talc. The capsule shells contain gelatin and titanium dioxide. In addition, the capsule shells contain iron oxide red and sodium lauryl sulfate. The markings on the capsules are in black ink, which contains black iron oxide, potassium hydroxide, propylene glycol, and shellac
RAN-PREGABALIN

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02392844
  • Active Ingredients :
    pregabalin
  • Innovator Name:
    Lyrica®
  • Category:
    Analgesic Agent
  • Dosage form:
    Capsule
  • Strength:
    150 mg
  • Package size:
    100 Bottle 500 Bottle
  • UPC Code:
    876515004778 876515004785
  • Non-medicinal ingredients :
    Mannitol and talc. The capsule shells contain gelatin and titanium dioxide. In addition, the capsule shells contain iron oxide red and sodium lauryl sulfate. The markings on the capsules are in black ink, which contains black iron oxide, potassium hydroxide, propylene glycol, and shellac
RAN-PREGABALIN

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02392852
  • Active Ingredients :
    pregabalin
  • Innovator Name:
    Lyrica®
  • Category:
    Analgesic Agent
  • Dosage form:
    Capsule
  • Strength:
    225 mg
  • Package size:
    100 Bottle 500 Bottle
  • UPC Code:
    876515004792 876515004808
  • Non-medicinal ingredients :
    Mannitol and talc. The capsule shells contain gelatin and titanium dioxide. In addition, the capsule shells contain iron oxide red and sodium lauryl sulfate. The markings on the capsules are in black ink, which contains black iron oxide, potassium hydroxide, propylene glycol, and shellac
RAN-PREGABALIN

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02392860
  • Active Ingredients :
    pregabalin
  • Innovator Name:
    Lyrica®
  • Category:
    Analgesic Agent
  • Dosage form:
    Capsule
  • Strength:
    300 mg
  • Package size:
    100 Bottle 500 Bottle
  • UPC Code:
    876515004815 876515004822
  • Non-medicinal ingredients :
    Mannitol and talc. The capsule shells contain gelatin and titanium dioxide. In addition, the capsule shells contain iron oxide red and sodium lauryl sulfate. The markings on the capsules are in black ink, which contains black iron oxide, potassium hydroxide, propylene glycol, and shellac
RAN-PREGABALIN

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here